The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Abstract
The Ras-dependent extracellular signal-regulated kinase (ERK)1/2 mitogen-activated protein (MAP) kinase pathway plays a central role in cell proliferation control. In normal cells, sustained activation of ERK1/ERK2 is necessary for G1- to S-phase progression and is associated with induction of positive regulators of the cell cycle and inactivation of antiproliferative genes. In cells expressing activated Ras or Raf mutants, hyperactivation of the ERK1/2 pathway elicits cell cycle arrest by inducing the accumulation of cyclin-dependent kinase inhibitors. In this review, we discuss the mechanisms by which activated ERK1/ERK2 regulate growth and cell cycle progression of mammalian somatic cells. We also highlight the findings obtained from gene disruption studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The sustained activation of ERK1/2 is necessary for the progression from G 1 phase to S phase and is associated with the upregulation of proliferation-associated genes and the downregulation of antiproliferative genes ( 56 ).”
From Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration (2017) · cites this paper as [56]
Citations
Cites
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787 · cited 1×
“…and cellular energy status to modulate ribosome biogenesis and translation initiation (see Fingar and Blenis, 2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1 (TSC1)/TSC2 heterodimer, which acts…”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 11×
“Oncogene Induction of D-type cyclins and assembly of cyclin D–Cdk4 complexes Various mechanisms have been proposed to explain how the ERK1/2 MAP kinase pathway regulates G1-phase progression, although a complete picture is yet to emerge.”
BackgroundInfluentialThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181 · cited 1×
“…from growth factors, nutrients and cellular energy status to modulate ribosome biogenesis and translation initiation (see Fingar and Blenis, 2004; Hay and Sonenberg, 2004; Wullschleger et al., 2006 for reviews). mTOR activity is negatively regulated by the tuberous sclerosis complex 1…”
BackgroundMitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 2×
“MAP kinase pathways are evolutionarily conserved signaling modules by which cells transduce extracellular signals into intracellular responses (reviewed in Lewis et al., 1998; Widmann et al., 1999; Pearson et al., 2001).”
BackgroundMitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729 · cited 1×
“MAP kinase pathways are evolutionarily conserved signaling modules by which cells transduce extracellular signals into intracellular responses (reviewed in Lewis et al., 1998; Widmann et al., 1999; Pearson et al., 2001).”
BackgroundA synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679 · cited 2×
“…inhibit the proliferation of various cell types, including fibroblasts, T lymphocytes, smooth muscle cells, hepatocytes and epithelial cell lines (Dudley et al., 1995; Seufferlein et al., 1996; Karpova et al., 1997; DeSilva et al., 1998; Williams et al., 1998; SeboltLeopold et al., 1999;…”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“The recent demonstration that ‘oncogene-induced senescence’ occurs in vivo and can be documented in pre-cancerous human melanocytic naevi (expressing B-Raf) or mouse lung adenomas (induced by K-Ras) has provided strong support for the physiological importance of this tumor suppression mechanism (Collado et al., 2005;…”
BackgroundCowley, S. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,966 · cited 3×
“Conversely, expression of constitutively active forms of MEK1 (Brunet et al., 1994; Cowley et al., 1994; Seger et al., 1994) relaxes growth factor dependency and enhances the rate of cell proliferation.”
BackgroundPagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817 · cited 1×
“One of the key mechanisms that regulates p27 abundance is proteolysis by the ubiquitin–proteasome pathway (Pagano et al., 1995). p27 is phosphorylated on Thr 187 by cyclin E–Cdk2 in late G1 (Sheaff et al., 1997; Vlach et al., 1997) and is then recognized and targeted for ubiquitination by the…”
Background
Cited by
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Mendoza, M. C., Er, E. E., & Blenis, J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.03.006 · Cited by 1,817
“Confoundingly, non-physiological hyper-activation of Ras-ERK signaling can induce the expression of CDK (cyclin-dependent kinase) inhibitors and trigger cell cycle arrest [5].”
BackgroundMitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
“The ERK MAPKs are regulated by the upstream MEK kinase (MAPK kinase) and at low levels induce cellular proliferation but at high levels cause growth arrest (18).”
BackgroundPhysiology of cell volume regulation in vertebrates
Hoffmann, E. K., Lambert, I. H., & Pedersen, S. F. (2009) · Physiological Reviews · doi:10.1152/physrev.00037.2007 · Cited by 1,441
Oxidative Stress in Aging Human Skin
Rinnerthaler, M., Bischof, J., Streubel, M., Trost, A., & Richter, K. (2015) · Biomolecules · doi:10.3390/biom5020545 · Cited by 1,053
“The tumor suppressor Rb is then in a complex with the E2F transcription factors, resulting in an inhibition of E2F target genes and a cell cycle arrest [343,345–351].”
Background
Metadata
- Authors
- Meloche, S., & Pouysségur, J.
- Affiliations
- Institute for Research in Immunology and Cancer (CA)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Meloche, S
- Pouysségur, J
- Venue
- Oncogene
- Published
- 2007-05-14
- Volume
- 26
- Issue
- 22
- Pages
- 3227-3239
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1983833034
- Cited by
- 1,091
- References
- 194
- Citations by year
- 2026: 31 · 2025: 26 · 2024: 35 · 2023: 43 · 2022: 47 · 2021: 65 · 2020: 54 · 2019: 58 · 2018: 60 · 2017: 68 · 2016: 48 · 2015: 61 · 2014: 69 · 2013: 68 · 2012: 79
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- ERK1/2, MAPK signaling, Ras signaling, G1/S transition, cell cycle progression, cell proliferation, cyclin-dependent kinase inhibitors, cell cycle arrest, Raf activation, somatic cells
- MeSH terms
- Animals, Enzyme Activation, Humans, G1 Phase, S Phase, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Mitogen-Activated Protein Kinase 3, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. https://app.cochat.ai/papers/10.1038/sj.onc.1210414
- The paper
- Meloche, S., & Pouysségur, J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. https://doi.org/10.1038/sj.onc.1210414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.